Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen
Charles J. Dimitroff, … , Thomas S. Kupper, Robert Sackstein
Charles J. Dimitroff, … , Thomas S. Kupper, Robert Sackstein
Published October 1, 2003
Citation Information: J Clin Invest. 2003;112(7):1008-1018. https://doi.org/10.1172/JCI19220.
View: Text | PDF
Article Dermatology

Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen

  • Text
  • PDF
Abstract

E-selectin and P-selectin on dermal postcapillary venules play critical roles in the migration of effector T cells into inflamed skin. P-selectin glycoprotein ligand-1 (PSGL-1) modified by α1,3-fucosyltransferase is the principal selectin ligand on skin-homing T cells and is required for effector T cell entry into inflamed skin. We have previously shown that a fluorinated analog of N-acetylglucosamine peracetylated-4-fluorinated-D-glucosamine (4-F-GlcNAc), inhibits selectin ligand expression on human T cell PSGL-1. To analyze 4-F-GlcNAc efficacy in dampening effector T cell migration to inflamed skin, we elicited allergic contact hypersensitivity (CHS) reactions in mice treated with 4-F-GlcNAc. We also investigated 4-F-GlcNAc efficacy on lymphocyte E-selectin ligand expression in LNs draining antigen-sensitized skin and on other immunological processes requisite for CHS responses. Our results showed that 4-F-GlcNAc treatment attenuated lymphocyte E-selectin ligand expression in skin-draining LNs and prevented CHS reactions. Significant reductions in inflammatory lymphocytic infiltrate were observed, while pathways related to antigenic processing and presentation and naive T cell recognition within skin-draining LNs were unaffected. These data indicate that 4-F-GlcNAc prevents CHS by inhibiting selectin ligand activity and the capacity of effector T cells to enter antigen-challenged skin without affecting the afferent phase of CHS.

Authors

Charles J. Dimitroff, Thomas S. Kupper, Robert Sackstein

×

Total citations by year

Year: 2022 2021 2020 2019 2018 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2005 2004 2003 Total
Citations: 1 2 2 1 3 1 1 1 1 3 3 1 3 2 2 3 2 1 33
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (33)

Title and authors Publication Year
Chemical tools to study bacterial glycans: a tale from discovery of glycoproteins to disruption of their function
Barrett K, Dube DH
Israel Journal of Chemistry 2022
Opportunities and Challenges of Bacterial Glycosylation for the Development of Novel Antibacterial Strategies
L Yakovlieva, JA Fülleborn, MT Walvoort
Frontiers in microbiology 2021
Glycans and Glycan-Binding Proteins as Regulators and Potential Targets in Leukocyte Recruitment
F Krautter, AJ Iqbal
Frontiers in Cell and Developmental Biology 2021
Selectins—The Two Dr. Jekyll and Mr. Hyde Faces of Adhesion Molecules—A Review
I Tvaroška, C Selvaraj, J Koča
Molecules (Basel, Switzerland) 2020
Metabolic inhibitors of bacterial glycan biosynthesis
DA Williams, K Pradhan, A Paul, IR Olin, OT Tuck, KD Moulton, SS Kulkarni, DH Dube
Chemical Science 2020
Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer
I Ferreira, M Carrascal, A Mineiro, A Bugalho, P Borralho, Z Silva, F Dall'olio, P Videira
International journal of oncology 2019
E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy
M Silva, PA Videira, R Sackstein
Frontiers in immunology 2018
Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation, and ERK1/2 and p38 MAPK activation
MA Carrascal, M Silva, JS Ramalho, C Pen, M Martins, C Pascoal, C Amaral, I Serrano, MJ Oliveira, R Sackstein, PA Videira
Molecular Oncology 2018
Thioglycosides Are Efficient Metabolic Decoys of Glycosylation that Reduce Selectin Dependent Leukocyte Adhesion
SS Wang, X Gao, V del Solar, X Yu, A Antonopoulos, AE Friedman, EK Matich, GE Atilla-Gokcumen, M Nasirikenari, JT Lau, A Dell, SM Haslam, RA Laine, KL Matta, S Neelamegham
Cell Chemical Biology 2018
Synthesis and in vitro cytotoxicity of acetylated 3-fluoro, 4-fluoro and 3,4-difluoro analogs of D-glucosamine and D-galactosamine
Š Horník, LČ Šťastná, P Cuřínová, J Sýkora, K Káňová, R Hrstka, I Císařová, M Dračínský, J Karban
Beilstein Journal of Organic Chemistry 2016
A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino)glycan biosynthesis, as evidenced by 6F-GalNAc (Ac3)
XM van Wijk, R Lawrence, VL Thijssen, SA van Broek, R Troost, M Scherpenzeel, N Naidu, A Oosterhof, AW Griffioen, DJ Lefeber, FL van Delft, TH van Kuppevelt
The FASEB Journal 2015
ST3Gal-4 is the primary sialyltransferase regulating the synthesis of E-, P-, and L-selectin ligands on human myeloid leukocytes
N Mondal, A Buffone, G Stolfa, A Antonopoulos, JT Lau, SM Haslam, A Dell, S Neelamegham
Blood 2014
Synthesis of N -acetyl Glucosamine Analogs as Inhibitors for Hyaluronan Biosynthesis
G Wasonga, Y Tatara, I Kakizaki, X Huang
Journal of Carbohydrate Chemistry 2013
Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome
CD Rillahan, A Antonopoulos, CT Lefort, R Sonon, P Azadi, K Ley, A Dell, SM Haslam, JC Paulson
Nature Chemical Biology 2012
Leveraging fluorinated glucosamine action to boost anti-tumor immunity
CJ Dimitroff
Current Opinion in Immunology 2012
Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology
TM Gloster, DJ Vocadlo
Nature Chemical Biology 2012
Metabolic inhibition of galectin-1-binding carbohydrates accentuates anti-tumor immunity
F Cedeno-Laurent, MJ Opperman, SR Barthel, D Hays, T Schatton, Q Zhan, X He, KL Matta, JG Supko, MH Frank, GF Murphy, CJ Dimitroff
Journal of Investigative Dermatology 2011
Understanding glycomechanics using mathematical modeling: a review of current approaches to simulate cellular glycosylation reaction networks
A Puri, S Neelamegham
Annals of Biomedical Engineering 2011
Peracetylated 4-Fluoro-glucosamine Reduces the Content and Repertoire of N- and O-Glycans without Direct Incorporation
SR Barthel, A Antonopoulos, F Cedeno-Laurent, L Schaffer, G Hernandez, SA Patil, SJ North, A Dell, KL Matta, S Neelamegham, SM Haslam, CJ Dimitroff
The Journal of biological chemistry 2011
Therapeutic Perspectives in Atopic Dermatitis
L Misery
Clinical Reviews in Allergy & Immunology 2010
Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins
DD Marathe, A Buffone, EV Chandrasekaran, J Xue, RD Locke, M Nasirikenari, JT Lau, KL Matta, S Neelamegham
Blood 2009
Analysis of physiologic E-selectin-mediated leukocyte rolling on microvascular endothelium
G Wiese, SR Barthel, CJ Dimitroff
Journal of visualized experiments : JoVE 2009
Regulation of Heparan Sulfate and Chondroitin Sulfate Glycosaminoglycan Biosynthesis by 4-Fluoro-glucosamine in Murine Airway Smooth Muscle Cells
J Nigro, A Wang, D Mukhopadhyay, M Lauer, RJ Midura, R Sackstein, VC Hascall
The Journal of biological chemistry 2009
Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression
K Yamanaka, CJ Dimitroff, RC Fuhlbrigge, M Kakeda, I Kurokawa, H Mizutani, TS Kupper
Journal of Allergy and Clinical Immunology 2008
Prophylaxis of acute GVHD: manipulate the graft or the environment?
AJ Barrett, KL Blanc
Best Practice & Research Clinical Haematology 2008
Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis
ME Gainers, L Descheny, SR Barthel, L Liu, MA Wurbel, CJ Dimitroff
Journal of immunology (Baltimore, Md. : 1950) 2007
Targeting selectins and selectin ligands in inflammation and cancer
SR Barthel, JD Gavino, L Descheny, CJ Dimitroff
Expert Opinion on Therapeutic Targets 2007
Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells
CJ Dimitroff, L Descheny, N Trujillo, R Kim, V Nguyen, W Huang, KJ Pienta, JL Kutok, MA Rubin
Cancer research 2005
Chemokines: Control of Primary and Memory T-Cell Traffic
P Schaerli, B Moser
Immunologic Research 2005
Interleukin-4 induced down-regulation of skin homing receptor expression by human viral-specific CD8 T cells may contribute to atopic risk of cutaneous infection
SL Seneviratne, L Jones, AS Bailey, RV Samuel, AP Black, GS Ogg
Clinical & Experimental Immunology 2005
New insights into atopic dermatitis
DY Leung, M Boguniewicz, MD Howell, I Nomura, QA Hamid
Journal of Clinical Investigation 2004
Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2
JC González, WW Kwok, A Wald, CL McClurkan, J Huang, DM Koelle
The Journal of Infectious Diseases 2004
Selectin and selectin ligand binding: a bittersweet attraction
TM Zollner, K Asadullah
Journal of Clinical Investigation 2003

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts